Explore a Novel Option for Postoperative Pain Control
John Barrington, MD, demonstrates the use of a novel long-acting bupivacaine liposome injectable suspension (EXPAREL®; Pacira, Parsippany, New Jersey) to manage the discomfort his patients experience following major joint replacement surgery.
The videos feature Dr. Barrington explaining how he infiltrates the wound site with EXPAREL during knee and hip replacement procedures. He prefers EXPAREL as part of his multimodal pain management strategy because it controls pain for up to 72 hours postoperatively.
Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam® drug delivery technology, for use in hospitals and ambulatory surgery centers. Learn more at www.pacira.com.